Environmental

Carbon footprint management: Auna has limited public disclosure on its direct and indirect greenhouse gas emissions, and there is no evidence of formalized decarbonization targets or progress reporting, which is below best practice for healthcare peers.

Resource efficiency: There is no evidence of significant investments in energy efficiency, water conservation, or waste reduction initiatives, and the company does not report on environmental KPIs, which is a material gap relative to leading regional healthcare operators.

Regulatory compliance: No material environmental violations or fines have been reported, and the company operates in jurisdictions with increasing environmental regulation, but its risk management disclosures are limited.

Auna’s environmental performance is moderate, with no major controversies but also no evidence of proactive management or disclosure on key environmental risks. The lack of transparency and formal targets leaves the company exposed to tightening regulatory and stakeholder expectations.

Social

Workforce management: Auna provides basic information on employee headcount and training, but lacks detailed disclosure on turnover, diversity, or labor relations, which is below best-in-class healthcare standards.

Patient safety and quality: The company highlights its focus on clinical quality and patient safety, but does not publish quantitative metrics or third-party accreditations, limiting comparability to global peers.

Community impact: Auna operates in underserved markets and provides access to healthcare services, which is a positive social contribution, but there is limited evidence of structured community engagement or impact measurement.

Auna’s social profile is moderate, with strengths in healthcare access but limited transparency on workforce and patient outcomes. The absence of robust disclosure and benchmarking constrains a full assessment of social risk and opportunity.

Governance

Board structure and independence: Auna’s board includes independent directors, but detailed information on board composition, diversity, and committee structure is limited compared to global governance standards.

Financial discipline and leverage: The company’s elevated net debt/EBITDA ratio of 4.31x indicates increased financial risk, which is a material governance concern for a healthcare operator.

Disclosure and transparency: Auna’s public reporting is less comprehensive than leading peers, with limited ESG and risk disclosures, which may hinder investor oversight.

Auna’s governance is moderate, with basic board independence but material concerns around leverage and limited transparency. Enhanced disclosure and risk management would be needed to align with best-in-class governance practices.

Overall Score

Auna’s ESG profile is moderate across all pillars. The company faces material gaps in environmental and social disclosure, and its high leverage elevates governance risk. While there are no major controversies, Auna lags best-in-class peers on transparency and proactive risk management, limiting its ESG upside.